You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

PARGYLINE HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for pargyline hydrochloride and what is the scope of freedom to operate?

Pargyline hydrochloride is the generic ingredient in one branded drug marketed by Abbott and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for PARGYLINE HYDROCHLORIDE
Recent Clinical Trials for PARGYLINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
VA Office of Research and Development
US Department of Veterans Affairs

See all PARGYLINE HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for PARGYLINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for PARGYLINE HYDROCHLORIDE

US Patents and Regulatory Information for PARGYLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott EUTONYL pargyline hydrochloride TABLET;ORAL 013448-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Abbott EUTONYL pargyline hydrochloride TABLET;ORAL 013448-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Abbott EUTONYL pargyline hydrochloride TABLET;ORAL 013448-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

PARGYLINE HYDROCHLORIDE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Pargyline Hydrochloride

Introduction to Pargyline Hydrochloride

Pargyline hydrochloride, a compound with the CAS number 555-57-7, is an irreversible inhibitor of monoamine oxidase (MAO), particularly targeting MAO-B. It has significant applications in medical research and treatment, especially in the fields of neurology and psychiatry.

Market Overview

Global and Chinese Market Status

The global and Chinese markets for pargyline hydrochloride are closely analyzed in market research reports. These reports provide a comprehensive overview of the industry, including market status, key statistics, and trends from 2012 to 2022 and beyond[1][4].

Market Drivers and Challenges

The global market for pargyline hydrochloride is driven by several factors:

  • Increasing Demand in Research: The drug's role in inhibiting MAO-B makes it crucial for research in neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.
  • Therapeutic Applications: Its use in clinical treatments for psychiatric and neurological disorders drives demand.
  • Advancements in Manufacturing Technology: Improvements in production methods and capacity expansions by manufacturers contribute to market growth[4].

However, the market also faces challenges:

  • Regulatory Hurdles: Strict regulations and safety standards can impact production and distribution.
  • Competition from Alternative Inhibitors: Other MAO inhibitors like selegiline and rasagiline may compete for market share[3][4].

Market Dynamics

Upstream Raw Materials and Downstream Demand

The market dynamics of pargyline hydrochloride are influenced by both upstream raw materials and downstream demand.

  • Upstream Raw Materials: The availability and cost of raw materials used in the production of pargyline hydrochloride can affect the overall production cost and market supply[4].
  • Downstream Demand: The demand from pharmaceutical companies, research institutions, and clinical settings drives the market. Changes in downstream demand can significantly impact the production volumes and prices of pargyline hydrochloride[1][4].

Global Market Forecast

Market forecasts indicate a steady growth in the demand for pargyline hydrochloride, driven by increasing research activities and therapeutic applications.

  • Capacity, Production, and Production Value: The global and Chinese markets are expected to see increases in capacity, production, and production value over the forecast period[1][4].
  • Market Share and Supply/Demand: The market share of key players is expected to shift based on their production capacities, technological advancements, and market strategies. The supply and demand dynamics will continue to influence prices and market stability[1][4].

Financial Trajectory

Production Costs and Profit Estimation

The financial trajectory of pargyline hydrochloride manufacturers is closely tied to production costs and profit margins.

  • Cost Analysis: The cost of raw materials, manufacturing processes, and regulatory compliance affects the overall cost structure. Efficient production methods and economies of scale can help reduce costs and increase profitability[1][4].
  • Profit Estimation: The profit margins are influenced by market demand, competition, and pricing strategies. Manufacturers with strong market positions and efficient operations are likely to maintain higher profit margins[1].

Market Share and Revenue

The market share of pargyline hydrochloride manufacturers is a critical factor in their financial performance.

  • Global and Chinese Market Share: Key players in the global and Chinese markets compete for market share based on their production capacities, product quality, and market reach. Companies with significant market shares tend to have higher revenues and better financial stability[1][4].

Import and Export Dynamics

The import and export dynamics play a crucial role in the financial trajectory of pargyline hydrochloride.

  • Chinese Import and Export: China is a significant player in the global pargyline hydrochloride market. The import and export activities of Chinese manufacturers impact the global supply chain and market prices[1].

Economic Impact

Global and Chinese Macroeconomic Environment

The macroeconomic environment in both global and Chinese contexts influences the pargyline hydrochloride market.

  • Global Macroeconomic Analysis: Global economic trends, such as GDP growth, inflation rates, and trade policies, affect the overall demand and supply of pargyline hydrochloride[1].
  • Chinese Macroeconomic Analysis: China's economic policies, industrial development strategies, and trade regulations significantly impact the Chinese market for pargyline hydrochloride[1].

Industry Chain Analysis

Industry Chain Structure

The industry chain for pargyline hydrochloride includes several key components:

  • Upstream Raw Materials: Suppliers of raw materials are crucial for the production process.
  • Manufacturing: The production process involves several stages, including synthesis, purification, and formulation.
  • Downstream Demand: Pharmaceutical companies, research institutions, and clinical settings are the primary consumers of pargyline hydrochloride[4].

Key Players and Market Strategies

Global and Chinese Manufacturers

The market is dominated by several key players, both globally and in China.

  • Manufacturers in Europe, Asia Pacific, and North America: Companies in these regions are significant producers and suppliers of pargyline hydrochloride. Their market strategies, including production capacity expansions, technological innovations, and pricing strategies, influence the market dynamics[4].

Suppliers and Distributors

Suppliers and distributors play a vital role in the market by ensuring the smooth flow of products from manufacturers to consumers.

  • Global Supply Chain: The global supply chain for pargyline hydrochloride involves a network of suppliers, distributors, and logistics providers. Efficient supply chain management is crucial for maintaining market stability and meeting demand[4].

Pricing and Market Trends

Global Pricing Trends

The prices of pargyline hydrochloride vary by region, influenced by local market conditions, competition, and regulatory factors.

  • Prices in Europe, Asia Pacific, and North America: Prices in these regions are determined by the balance of supply and demand, as well as the presence of local manufacturers and suppliers[4].

Market Trends and Prospects

The market trends for pargyline hydrochloride are positive, driven by increasing demand and advancements in manufacturing technology.

  • Downstream Market Trends: The trends in downstream markets, such as pharmaceuticals and research, influence the demand for pargyline hydrochloride. Growing research in neurodegenerative diseases is expected to drive the market forward[4].

Conclusion

The market dynamics and financial trajectory of pargyline hydrochloride are influenced by a complex interplay of factors including market demand, production costs, regulatory environment, and global economic trends. As the demand for this drug continues to grow, manufacturers and suppliers must adapt to changing market conditions to maintain their competitive edge.

Key Takeaways

  • Increasing Demand: Growing demand from research and therapeutic applications drives the market.
  • Market Drivers: Advancements in manufacturing technology and increasing research activities are key drivers.
  • Challenges: Regulatory hurdles and competition from alternative inhibitors are significant challenges.
  • Financial Performance: Production costs, profit margins, and market share are critical for financial stability.
  • Global and Chinese Markets: Both markets are significant, with China playing a crucial role in global supply and demand.
  • Industry Chain: The industry chain includes upstream raw materials, manufacturing, and downstream demand.

FAQs

What is pargyline hydrochloride used for?

Pargyline hydrochloride is used as an irreversible inhibitor of monoamine oxidase (MAO), particularly targeting MAO-B. It has applications in medical research and treatment of neurodegenerative diseases like Parkinson's disease and Alzheimer's disease[3][5].

Who are the key players in the pargyline hydrochloride market?

The market includes manufacturers from Europe, Asia Pacific, and North America. Key players are identified based on their production capacities, market reach, and technological innovations[4].

What are the main drivers of the pargyline hydrochloride market?

The main drivers include increasing demand from research and therapeutic applications, advancements in manufacturing technology, and growing research in neurodegenerative diseases[4].

How does the global economic environment impact the pargyline hydrochloride market?

The global economic environment, including GDP growth, inflation rates, and trade policies, affects the overall demand and supply of pargyline hydrochloride. China's economic policies also significantly impact the market[1].

What are the challenges faced by the pargyline hydrochloride market?

The market faces challenges such as regulatory hurdles, competition from alternative MAO inhibitors, and fluctuations in raw material costs[4].

Sources

  1. Global and Chinese Pargyline Hydrochloride Industry, 2012-2022 Market Research Report. Market Publishers.
  2. RULES AND REGULATIONS Governing GREYHOUND RACING In .... Arkansas State Legislature.
  3. mao inhibitor pargyline: Topics by Science.gov. Science.gov.
  4. Pargyline hydrochloride Market Research Report 2024. Market Publishers.
  5. Pargyline hydrochloride | 99.99%(HPLC) | In Stock | MAO inhibitor. Selleck Chemicals.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.